4//SEC Filing
D'Adamio Anthony 4
Accession 0001578563-25-000184
CIK 0001665988other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 5:33 PM ET
Size
5.4 KB
Accession
0001578563-25-000184
Insider Transaction Report
Form 4
D'Adamio Anthony
SVP & General Counsel
Transactions
- Sale
Class A Common Stock
2025-03-17$9.75/sh−2,615$25,496→ 124,449 total
Footnotes (2)
- [F1]Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 14, 2025 pursuant to a standing 10b5-1 instruction adopted on March 14, 2022.
- [F2]The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $9.56 to $10.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Bioventus Inc.
CIK 0001665988
Entity typeother
Related Parties
1- filerCIK 0001835184
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 5:33 PM ET
- Size
- 5.4 KB